First drug to slow Alzheimer’s off to sluggish start
The first drug shown to slow Alzheimer’s disease hit the United States market over a year ago, but sales have lagged, major hospital systems have taken months to start using it, and some insurers have rejected coverage. Doctors also expect some patients …